$156.28 Nov 18, 2026 · market cap $298B
Novartis trades at $156. Our two models put it at $41–$139 (base $139): above both. Owner earnings gives no value here, so the base is the Cash Flow model. The models disagree widely, so read the base with care.
Cash Flow $139 · Damodaran $41 · models run Nov 18, 2026
13 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app